ABHD10

Palmitoyl-protein thioesterase ABHD10, mitochondrial · Q9NUJ1 · ABHD10 on Sugi Atlas →

699 patent compounds predicted against ABHD10, 511 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL15321687 SCHEMBL15321687 1.00 2/20
SCHEMBL15326055 SCHEMBL15326055 1.00 2/20
SCHEMBL15326048 SCHEMBL15326048 0.74 2/20
SCHEMBL15326056 SCHEMBL15326056 0.69 2/20
SCHEMBL15326063 SCHEMBL15326063 0.66 2/20
SCHEMBL15326051 SCHEMBL15326051 0.65 2/20
SCHEMBL15326053 SCHEMBL15326053 0.52 2/20
SCHEMBL31556611 SCHEMBL31556611 0.88 1/20
SCHEMBL17396592 SCHEMBL17396592 0.75 1/20
SCHEMBL17396593 SCHEMBL17396593 0.75 1/20
SCHEMBL17414016 SCHEMBL17414016 0.72 1/20
SCHEMBL18836259 SCHEMBL18836259 0.72 1/20
SCHEMBL18836260 SCHEMBL18836260 0.72 1/20
SCHEMBL18854661 SCHEMBL18854661 0.72 1/20
SCHEMBL24180211 SCHEMBL24180211 0.72 1/20
SCHEMBL17414107 SCHEMBL17414107 0.71 1/20
SCHEMBL18836092 SCHEMBL18836092 0.71 1/20
SCHEMBL29532250 SCHEMBL29532250 0.71 1/20
Rocagloic Acid Rocagloic Acid (SCHEMBL750035) 0.69 1/20
Rocagloic Acid Rocagloic Acid (SCHEMBL752143) 0.69 1/20

Clinical trials — most relevant to ABHD10 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis PHASE4COMPLETED
Betaine and Peroxisome Biogenesis Disorders PHASE3COMPLETED
The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC PHASE1/PHASE2UNKNOWN
Clinical Trial of High Dose CoQ10 in ALS PHASE2COMPLETED
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma PHASE2COMPLETED
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis PHASE2UNKNOWN
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) EARLY_PHASE1COMPLETED
Fatty Acid Oxidation Defects and Insulin Sensitivity nanCOMPLETED
Tissue Sample Study for Mitochondrial Disorders nanENROLLING_BY_INVITATION
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide nanRECRUITING
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy nanCOMPLETED
A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular Powerhouse) Dysfunction nanCOMPLETED
Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip nanCOMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Mitochondrial Membrane Protein Neurodegeneration (MPAN) nanCOMPLETED
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes nanRECRUITING
A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders nanCOMPLETED
Heart and Muscle Metabolism in Barth Syndrome nanCOMPLETED
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) nanRECRUITING
Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine nanCOMPLETED
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants nanRECRUITING
Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS nanRECRUITING
GDF-15 as a Biomarker for Mitochondrial Disease nanCOMPLETED
Effect of Short-Term Exercise Training on ATP Synthesis in Relatives of Type 2 Diabetic Humans nanCOMPLETED
Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH nanCOMPLETED
Assessing the Role of Mitochondrial Dysfunction in Primary Progressive Multiple Sclerosis nanUNKNOWN
Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ABHD10 binder may also engage these)

ProteinNameSimilarity
Q5E9H9 1.000 Q5E9H9 →
Q5REX5 1.000 Q5REX5 →
Q5I0K5 1.000 Q5I0K5 →
Q6PE15 0.997 Q6PE15 →
Q7T0X7 0.969 Q7T0X7 →
Q90678 0.969 Q90678 →
A4IHY0 0.968 A4IHY0 →
Q8R164 0.968 Q8R164 →
P83006 0.964 P83006 →
Q8VE38 0.964 Q8VE38 →
Q58DM7 0.964 Q58DM7 →
Q8VDG7 0.963 Q8VDG7 →
Q96QE5 0.963 Q96QE5 →
Q5RJG7 0.963 Q5RJG7 →
O77480 0.962 O77480 →
A0JPF9 0.962 A0JPF9 →
P79106 0.962 P79106 →
E1BCH6 0.962 E1BCH6 →
Q99487 0.962 Q99487 →
Q9W758 0.961 Q9W758 →
P98192 0.961 P98192 →
Q5R4D2 0.961 Q5R4D2 →
Q5S6T3 0.961 Q5S6T3 →
Q6DJF8 0.961 Q6DJF8 →
Q94E75 0.961 Q94E75 →
A6QPR9 0.960 A6QPR9 →
Q566R0 0.960 Q566R0 →
Q5I0C5 0.960 Q5I0C5 →
Q9EPB5 0.959 Q9EPB5 →
A5A6K6 0.959 A5A6K6 →